Stay updated on Dapagliflozin and Metformin in GDM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.

Latest updates to the Dapagliflozin and Metformin in GDM Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page adds a recruitment-status note indicating no longer looking for participants and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading formatting to a different style.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page shows Revision: v3.5.5 instead of v3.5.4, indicating a software version update with no evident changes to the study details.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a deployment/patch to the ClinicalTrials.gov interface rather than changes to the study content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s display/version marker was updated from v3.5.2 to v3.5.3, indicating a site release change rather than any modification to the study record.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision from v3.5.0 to v3.5.2 was applied. The older revision v3.5.0 was removed.SummaryDifference0.1%

- Check93 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin and Metformin in GDM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.